SG10201705118RA - Dna element having the activity of enhancing foreign gene expression - Google Patents

Dna element having the activity of enhancing foreign gene expression

Info

Publication number
SG10201705118RA
SG10201705118RA SG10201705118RA SG10201705118RA SG10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA
Authority
SG
Singapore
Prior art keywords
activity
gene expression
foreign gene
dna element
enhancing foreign
Prior art date
Application number
SG10201705118RA
Other languages
English (en)
Inventor
Nishimiya Daisuke
Inoue Tatsuya
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SG10201705118RA publication Critical patent/SG10201705118RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201705118RA 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression SG10201705118RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010154782 2010-07-07

Publications (1)

Publication Number Publication Date
SG10201705118RA true SG10201705118RA (en) 2017-07-28

Family

ID=44630215

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10201705118RA SG10201705118RA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG10201505354PA SG10201505354PA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2012094330A SG186788A1 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2014009187A SG2014009187A (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG10201505354PA SG10201505354PA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2012094330A SG186788A1 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2014009187A SG2014009187A (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Country Status (14)

Country Link
US (3) US9371543B2 (cg-RX-API-DMAC7.html)
EP (3) EP2591113B1 (cg-RX-API-DMAC7.html)
JP (2) JP5859988B2 (cg-RX-API-DMAC7.html)
KR (3) KR101856927B1 (cg-RX-API-DMAC7.html)
CN (3) CN103080321A (cg-RX-API-DMAC7.html)
AU (3) AU2011274864B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012033780A2 (cg-RX-API-DMAC7.html)
CA (2) CA2916937A1 (cg-RX-API-DMAC7.html)
ES (3) ES2565428T3 (cg-RX-API-DMAC7.html)
IL (1) IL243763A0 (cg-RX-API-DMAC7.html)
RU (1) RU2013104989A (cg-RX-API-DMAC7.html)
SG (4) SG10201705118RA (cg-RX-API-DMAC7.html)
TW (2) TW201604280A (cg-RX-API-DMAC7.html)
WO (1) WO2012005378A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2591113B1 (en) * 2010-07-07 2016-01-20 Daiichi Sankyo Company, Limited Dna element having the activity of enhancing foreign gene expression
CN104066839B (zh) * 2011-11-28 2018-02-16 第一三共株式会社 衍生自人基因的启动子
JP7382138B2 (ja) * 2016-10-03 2023-11-16 第一三共株式会社 Hspa5遺伝子のプロモーター
CN107881174B (zh) * 2017-11-22 2022-06-03 张宝会 一种翻译水平基因表达调控的方法及应用
WO2020034097A1 (en) * 2018-08-14 2020-02-20 Wuxi Biologics (Shanghai) Co., Ltd. Transcriptional regulatory element and its use in enhancing the expression of exogenous protein
US20230192893A1 (en) * 2020-05-11 2023-06-22 Samsung Bioepis Co., Ltd. Human genome-derived polynucleotide and method for producing polypeptide of interest using same
WO2023210607A1 (ja) 2022-04-26 2023-11-02 第一三共株式会社 Eno1遺伝子のプロモーター

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611263B2 (en) * 1988-02-12 1991-06-06 Commonwealth Scientific And Industrial Research Organisation Pox virus vectors
US20070161003A1 (en) * 2003-09-29 2007-07-12 Morris David W Novel therapeutic targets in cancer
EP2105742A1 (en) * 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
JP5344682B2 (ja) * 2008-12-26 2013-11-20 グローブライド株式会社 釣糸ガイド、及び釣糸ガイドの製造方法
EP2591113B1 (en) * 2010-07-07 2016-01-20 Daiichi Sankyo Company, Limited Dna element having the activity of enhancing foreign gene expression
CN104066839B (zh) * 2011-11-28 2018-02-16 第一三共株式会社 衍生自人基因的启动子

Also Published As

Publication number Publication date
US20160333371A1 (en) 2016-11-17
US10407694B2 (en) 2019-09-10
CN103865931B (zh) 2018-10-02
KR101920187B1 (ko) 2018-11-19
US20130171694A1 (en) 2013-07-04
US11060108B2 (en) 2021-07-13
EP3026117B1 (en) 2018-09-12
KR101856927B1 (ko) 2018-05-10
JP2013531967A (ja) 2013-08-15
TW201604280A (zh) 2016-02-01
CA2916937A1 (en) 2012-01-12
CN105950621B (zh) 2019-07-30
AU2018200686A1 (en) 2018-02-22
AU2011274864B2 (en) 2016-10-06
WO2012005378A3 (en) 2012-04-12
CN103865931A (zh) 2014-06-18
CN105950621A (zh) 2016-09-21
JP2016054741A (ja) 2016-04-21
WO2012005378A2 (en) 2012-01-12
IL243763A0 (en) 2016-04-21
JP5859988B2 (ja) 2016-02-16
KR20180021246A (ko) 2018-02-28
CN103080321A (zh) 2013-05-01
US20190345515A1 (en) 2019-11-14
AU2011274864A1 (en) 2013-02-07
ES2565428T3 (es) 2016-04-04
CA2804381A1 (en) 2012-01-12
TWI507523B (zh) 2015-11-11
SG10201505354PA (en) 2015-08-28
EP2684961A1 (en) 2014-01-15
KR20130111514A (ko) 2013-10-10
JP6039048B2 (ja) 2016-12-07
KR20180021247A (ko) 2018-02-28
EP3026117A1 (en) 2016-06-01
CA2804381C (en) 2016-03-22
AU2018200686B2 (en) 2020-02-13
KR101833570B1 (ko) 2018-03-02
BR112012033780A2 (pt) 2016-05-31
TW201207103A (en) 2012-02-16
EP2684961B1 (en) 2016-01-20
AU2016203681A1 (en) 2016-06-23
SG186788A1 (en) 2013-02-28
ES2564227T3 (es) 2016-03-21
EP2591113B1 (en) 2016-01-20
ES2701091T3 (es) 2019-02-20
SG2014009187A (en) 2014-04-28
US9371543B2 (en) 2016-06-21
AU2016203681B2 (en) 2018-04-19
EP2591113A2 (en) 2013-05-15
RU2013104989A (ru) 2014-08-20

Similar Documents

Publication Publication Date Title
PL2612917T3 (pl) Antysensowy kwas nukleinowy
IL215571A0 (en) Plant snfi-related protein kinase gene
LT2844750T (lt) Pagerinti fermento variantai
IL218206A0 (en) Photobioreactor
EP2487238A4 (en) SUSCEPTIBILITY FOR HAIR FORMS
GB201004475D0 (en) Gene silencing
ZA201304998B (en) Dna expression construct
IL243763A0 (en) A DNA element with the activity of increasing the expression of a foreign gene and its uses
EP2508602A4 (en) SUSCEPTIBILITY FOR HAIR FORMS
EP2649993A4 (en) STABILIZER OF ACETAMINOPHENE
IL226536A (en) DNA position-oriented change
GB2502195B (en) Purification of nucleic acids
EP2487239A4 (en) SUSCEPTIBILITY GENE WITH HAIR FORMS
EP2844775A4 (en) DNA SEQUENCING
IL232848A0 (en) Human gene derived promoter
ZA201400484B (en) Nucleic acid molecules encoding enzymes that confer disease resistance injute
IL226537A (en) Position-directed change of DNA with oligonucleotides
EP2536741A4 (en) THERAPY TARGETING FUSIONS OF GENES
EP2535415A4 (en) MODIFIED XYLANASE NUCLEOTIDE MOLECULES AND THEIR APPLICATIONS
GB201010471D0 (en) Gene variant
GB201021720D0 (en) Gene variant
GB201215484D0 (en) Optical characterisation of DNA and/or RNA
GB201009217D0 (en) Targeted gene therapy
GB201004862D0 (en) DNA amplification
GB201021659D0 (en) An isolated nucleic acid and uses thereof